Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Earl HM, Hiller L, Vallier AL, Loi S, McAdam K, Hughes-Davies L, Harnett AN, Ah-See ML, Simcock R, Rea D, Raj S, Woodings P, Harries M, Howe D, Raynes K, Higgins HB, Wilcox M, Plummer C, Mansi J, Gounaris I, Mahler-Araujo B, Provenzano E, Chhabra A, Abraham JE, Caldas C, Hall PS, McCabe C, Hulme C, Miles D, Wardley AM, Cameron DA, Dunn JA; PERSEPHONE Steering Committee and Trial Investigators. Earl HM, et al. Lancet. 2019 Jun 29;393(10191):2599-2612. doi: 10.1016/S0140-6736(19)30650-6. Epub 2019 Jun 6. Lancet. 2019. PMID: 31178152 Free PMC article. Clinical Trial.
Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer.
Currie DC, Miles DW, Drake JS, Rudd R, Spiro SG, Earl HM, Harper PG, Tobias JS, Souhami RL. Currie DC, et al. Among authors: earl hm. Cancer Chemother Pharmacol. 1990;25(5):380-1. doi: 10.1007/BF00686243. Cancer Chemother Pharmacol. 1990. PMID: 2155066
Etoposide protein binding in cancer patients.
Liu B, Earl HM, Poole CJ, Dunn J, Kerr DJ. Liu B, et al. Among authors: earl hm. Cancer Chemother Pharmacol. 1995;36(6):506-12. doi: 10.1007/BF00685801. Cancer Chemother Pharmacol. 1995. PMID: 7554043
Chemotherapy of malignant fibrous histiocytoma of bone.
Earl HM, Pringle J, Kemp H, Morittu L, Miles D, Souhami R. Earl HM, et al. Ann Oncol. 1993 May;4(5):409-15. doi: 10.1093/oxfordjournals.annonc.a058521. Ann Oncol. 1993. PMID: 8394734 Free article. Clinical Trial.
A phase II study of Tomudex in relapsed epithelial ovarian cancer.
Gore ME, Earl HM, Cassidy J, Tattersall M, Mansi J, Seymour L, Azab M. Gore ME, et al. Among authors: earl hm. Ann Oncol. 1995 Sep;6(7):724-5. doi: 10.1093/oxfordjournals.annonc.a059291. Ann Oncol. 1995. PMID: 8664196 Free article. Clinical Trial. No abstract available.
Whither high-dose chemotherapy in breast cancer?
Mayer A, Earl H. Mayer A, et al. Breast Cancer Res. 2001;3(1):8-10. doi: 10.1186/bcr262. Epub 2000 Nov 8. Breast Cancer Res. 2001. PMID: 11250740 Free PMC article. Review.
140 results